ClinicalTrials.gov
ClinicalTrials.gov Menu

Sequential Bacillus Calmette-Guérin (BCG) and Electromotive Mitomycin-C Versus Bacillus Calmette-Guérin (BCG) Alone for High Risk Superficial Bladder Cancer (BCG/EMDA-MMC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01442519
Recruitment Status : Completed
First Posted : September 28, 2011
Last Update Posted : September 28, 2011
Sponsor:
Collaborator:
University of L'Aquila
Information provided by (Responsible Party):
Savino M. Di Stasi, University of Rome Tor Vergata